[Drug development from phospholipids].
Unger
C
C
Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg. unger@tumorbio.uni-freiburg.de
Eibl
H
H
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry*; D018906:Antineoplastic Agents, Alkylating / Q000737:chemistry; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008081:Liposomes; D009369:Neoplasms / Q000188:drug therapy*; D010743:Phospholipids / Q000737:chemistry*; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000737:chemistry; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D008081:Liposomes; D010743:Phospholipids; D010767:Phosphorylcholine; C039128:miltefosine